Intuitive Surgical Inc. (ISRG): Today's Featured Health Care Loser

Intuitive Surgical ( ISRG) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole closed the day down 1.2%. By the end of trading, Intuitive Surgical fell $19.62 (-3.6%) to $531.77 on heavy volume. Throughout the day, 637,975 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 305,200 shares. The stock ranged in price between $527.44-$547.85 after having opened the day at $545.61 as compared to the previous trading day's close of $551.39. Other company's within the Health Care sector that declined today were: MAKO Surgical Corporation ( MAKO), down 43.1%, Rexahn Pharmaceuticals ( RNN), down 31%, Questcor Pharmaceuticals ( QCOR), down 21.8%, and Stereotaxis ( STXS), down 15.3%.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems for various surgical procedures, including urologic, gynecologic, cardiothoracic, general, and head and neck surgeries. Intuitive Surgical has a market cap of $21.89 billion and is part of the health services industry. The company has a P/E ratio of 41.7, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 17.7. Shares are up 19.1% year to date as of the close of trading on Monday. Currently there are five analysts that rate Intuitive Surgical a buy, no analysts rate it a sell, and eight rate it a hold.

TheStreet Ratings rates Intuitive Surgical as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value.

On the positive front, Sunshine Heart ( SSH), up 37.8%, BioMimetic Therapeutics ( BMTI), up 23.6%, K-V Pharmaceutical Company ( KV.A), up 13.3%, and Hooper Holmes ( HH), up 12.1%, were all gainers within the health care sector with Hologic ( HOLX) being today's featured health care sector winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

If you liked this article you might like

The Method Behind My Investing Madness: Cramer's 'Mad Money' Recap (Wed 9/6/17)

Novartis AG, Sirius XM Radio, Coupa Software: 'Mad Money' Lightning Round

August's Inexplicable Selloffs Are Here: Cramer's 'Mad Money' Recap (8/17/17)

Blue Apron, Philip Morris, Honeywell, Becton Dickinson: 'Mad Money' Lightning Round